Press Releases
These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email and RSS tools below.
Archives: Search / 2022 / 2021 / 2020 / 2019 / 2018 / 2017 / 2016 / 2015 / 2014 / 2013
The research examines Dario's ability to improve the health of members in rural areas compared to their urban counterparts and found the solution to be equally effective NEW YORK, Aug. 12, 2022...
MoreDario's digital behavioral health solution will help to improve access and navigation across mental health resources NEW YORK, Aug. 11, 2022 /PRNewswire/ -- DarioHealth Corp. ("Dario",...
MoreDarioHealth Corp. (NASDAQ: DRIO), a leader in the global digital therapeutics (DTx) market, today announced it would release its financial results for the second quarter ended June 30, 2022, on...
MoreThe studies underscore the value of Dario's integrated behavioral health solution to help more people connect to effective care that is right for their needs NEW YORK, Aug. 4, 2022 /PRNewswire/ --...
MoreDemand for Dario's single approach to chronic condition management continues to show strong demand NEW YORK, July 21, 2022 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global...
MoreDarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, today announced a new contract to deliver its digital behavioral health solution for a leading provider...
MoreInvestment from Elite Healthcare Fund Provides Validation, Access to Capital and Significant Runway to Execute on Strategic Operating Plan NEW YORK, June 9, 2022 /PRNewswire/ -- DarioHealth Corp....
MoreThe studies demonstrated significant improvement in glucose control and reductions in blood pressure for users managing diabetes and hypertension and improvement in clinical measures for users...
MoreTwo new B2B contracts reinforce Dario's position as an emerging leader in multi-chronic digital health NEW YORK, May 19, 2022 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leader in the...
MoreTotal Q1 revenue of $8.06 million increased 124% over the comparable prior year period and 34% sequentially over Q4 2021 Accelerated Business-to-Business (B2B) transformation with 14 new B2B...
MoreDarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, today announced it would release its financial results for the first quarter ended March 31, 2022 on...
MoreNew research offers fresh evidence that a single digital therapeutics platform can improve outcomes for commonly co-occurring conditions NEW YORK, April 27, 2022 /PRNewswire/ -- DarioHealth Corp....
More